In a recent study published in The New England Journal of Medicine, researchers conducted the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) ...

Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no beta-blocker therapy in the subgroup of ...

Beta-blocker therapy after myocardial infarction (MI) failed to lower the rate of all-cause death, MI, or heart failure in patients with a left ventricular ejection fraction (LVEF) of at least 50%, ...

Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...

A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide clear benefits for heart attack patients ...

Madrid, Spain – 30 August 2025: Beta-blocker therapy showed no evidence of an effect on all-cause death, reinfarction or heart failure admission in patients with myocardial infarction (MI) managed ...

Decades after beta blockers became standard therapy following heart attacks, new research is challenging their routine use. Conducted across 109 hospitals in Spain and Italy and published in The New ...

For roughly four decades, the playbook after a heart attack has included a near-automatic prescription: beta-blockers, taken daily, often for life. The drugs became standard in the 1980s after ...

A major new analysis from the REBOOT (Treatment with Beta-blockers after Myocardial Infarction without Reduced Ejection Fraction) clinical trial, an international study coordinated by the Centro ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...